Aardvark Therapeutics, Inc. AARD
NASDAQ · United States · Health Technology
$5.270.00 (0.00%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.66 | -0.87 | +24.5% | $0 | — | -13.1%$7.56→$6.57 |
| Q1 2026 | 2026-05-07 | -0.99 | -0.81 | -22.2% | — | — | -7.6%$5.89→$5.44 |
| Q4 2025 | 2026-03-23 | -0.81 | -0.83 | +2.4% | — | — | -7.4%$4.07→$3.77 |
| Q3 2025 | 2025-11-13 | -0.75 | -0.82 | +8.5% | — | — | -7.5%$10.73→$9.92 |
| Q4 2024 | 2025-03-31 | -2.18 | -0.20 | -990.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.